The European Commission has opened a call for evidence on Biotech Act II, the second part of the European Biotech Act package, which will focus on industrial biotechnology and biomanufacturing. It follows the health-focused Biotech Act I, proposed on December 16, 2025, and is expected as a legislative proposal in the third/fourth quarter of 2026. The call invites a broad range of stakeholders to contribute across the industrial biotechnology and biomanufacturing value chain, with potential implications for agricultural inputs and food and feed ingredients.